ALK i
Interviews and expert commentary tagged “ALK i” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Second-Generation ALK Inhibitor = Longer PFS in ALK+ Lung Cancer After Crizotinib
COPENHAGEN—Longer progression free survival (PFS) was achieved in patients with ALK-rearranged non-small cell lung cancer (NSCLC) previously treated with crizotinib randomised to treatment with the se
8 December 2016
8:52 secs